|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Fiduciary assets (includes fiduciary cash of $7,947 in 2026 and $7,142 in 2025) | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets - net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Amortizable intangible assets - net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Fiduciary liabilities | ||||||||||||||||||||
| Accrued compensation and other current liabilities | ||||||||||||||||||||
| Deferred revenue - current | ||||||||||||||||||||
| Premium financing debt | ||||||||||||||||||||
| Corporate related borrowings - current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Corporate related borrowings - noncurrent | ||||||||||||||||||||
| Deferred revenue - noncurrent | ||||||||||||||||||||
| Lease liabilities - noncurrent | ||||||||||||||||||||
| Other noncurrent liabilities (includes tax credit carryforwards of $628 in 2026 and $713 in 2025) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock - issued and outstanding 256 shares in 2026 and 257 shares in 2025 | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Stockholders' equity attributable to controlling interests | ||||||||||||||||||||
| Stockholders' equity attributable to noncontrolling interests | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
